Amanote Research
Register
Sign In
168 a Rapid Evidence Assessment of the Optimal Phenobarbital Dosage Regimen for Management of Intractable Agitation in the Last Days of Life to Produce a Clinical Guideline
doi 10.1136/bmjspcare-2018-aspabstracts.195
Full Text
Open PDF
Abstract
Available in
full text
Date
March 1, 2018
Authors
R Allan
M Curtis
P-J Morey
Publisher
British Medical Journal Publishing Group
Related search
94 Guideline Development for the Management of Agitation in the Last Weeks of Life
An Updated Review of the Optimal Lithium Dosage Regimen for Renal Protection
Canadian Journal of Psychiatry
Psychiatry
Mental Health
Care in the Last Hours and Days of Life
Medicine
Medicine
A New Evidence-Based Guideline for Assessment and Management of Polycystic Ovary Syndrome
Medical Journal of Australia
Medicine
Palliative Radiation Therapy in the Last 30 Days of Life: A Systematic Review
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Clinical Practice Guideline on the Optimal Radiotherapeutic Management of Brain Metastases
BMC Cancer
Cancer Research
Oncology
Genetics
Barriers to Implementing an Integrated Care Pathway for the Last Days of Life in Nursing Homes
International Journal of Palliative Nursing
Specialized Nursing
Advanced
Clinical Guideline for the Management of Odontogenic Infections in the Tertiary Setting
Australian Dental Journal
Dentistry
A Network Meta-Analysis of Clinical Management Strategies for Treatment-Resistant Hypertension: Making Optimal Use of the Evidence
Journal of General Internal Medicine
Internal Medicine
